Tachykinin Nk3 Receptor Contribution to Systemic Release of Vasopressin and Oxytocin in Response to Osmotic and Hypotensive Challenge.
From: Graduate Neuroscience Program, University of Wyoming, Laramie, WY 82071, USA.
American journal of physiology. Regulatory, integrative and comparative physiology
- Publish Date: Aug 2007
- ISSN: 0363-6119
- Volume: 293
- Issue: 2
- Pages: R931-7
- Medium: Print
- Language: English
- Citation (JAMA): Haley Gwendolen E, Flynn Francis W, et al. Tachykinin Nk3 Receptor Contribution to Systemic Release of Vasopressin and Oxytocin in Response to Osmotic and Hypotensive Challenge.. Am. J. Physiol. Regul. Integr. Comp. Physiol. Aug 2007;293:R931-7
Abstract
Activation of the neurokinin 3 receptor (NK3R) by a receptor agonist, hypotension, and hyperosmolarity results in the internalization of NK3R expressed by magnocellular neurons and the release of vasopressin (VP) and oxytocin (OT) into the circulation. The contribution of NK3R activation to the release of VP and OT in response to hyperosmolarity and hypotension was evaluated by measuring the release of both hormones following pretreatment with a selective NK3R antagonist, SB-222200. Freely behaving male rats were given an intraventricular injection of either 0.15 M NaCl or 250, 500, or 1,000 pmol SB-222200, and then were administered an intravenous infusion of 2 M NaCl or 0.15 M NaCl (experiment 1), or a bolus intra injection of 0.15 M NaCl or hydralazine (HDZ), a hypotension-inducing drug (experiment 2). Blood samples were taken from indwelling arterial catheters at various time points for 1-2 h, both before and after treatments. Plasma VP and OT levels were determined by ELISA. Blockade of NK3R did not affect the baseline levels of either hormone. In contrast, pretreatment with SB-222200 significantly reduced ( approximately 60%) or abolished the release of VP and OT, respectively, to 2 M NaCl infusion. HDZ-induced VP and OT release was eliminated by pretreatment with 500 pmol SB-222200. Therefore, NK3R activation contributes significantly to the systemic release of both VP and OT in response to osmotic and hypotensive challenges.
Mesh Headings (Keywords): Animals, Hydralazine, Hypotension, Hypothalamus, Infusions, Intravenous, Injections, Intraventricular, Male, Osmotic Pressure, Oxytocin, Quinolines, Rats, Receptors, Neurokinin-3, Sodium Chloride, Vasodilator Agents, Vasopressins, Water-Electrolyte Balance
Check for Full Text / PubMed Unique Identifier (PMID): 17522129
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.